Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Help FDA Develop QC Standards for Genomic Data

NEW YORK (GenomeWeb News) - Gene Logic said today that it will work with the US Food and Drug Administration to develop quality control metrics that will help the agency assess the quality of genomic data submissions.
 
The collaboration is part of FDA's Critical Path Initiative. Gene Logic said that the collaboration's results will be released publicly as "an early step towards formulating industry-wide standards" for assessing genomic data. The company said that there are currently no such standards in place.
 
Donna Mendrick, vice president of toxicogenomics at Gene Logic, said in a statement that the project is “a step on the path to achieving a common understanding of key microarray QC procedures that may lead to the development of preliminary microarray data standards for the submission of microarray data to the FDA."

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.